We have shared our perspectives about the proposed changes to the Patented Medicine Prices Review Board (PMPRB) over the years. We continued to share the need for PMPRB to actively engage with patients, or people with lived or living experience, in all aspects of their operations, and how patient communities can provide feedback on the value and outcomes of interest. Learn more by reading our submission.